www.buttermilkbar.com, Asian, African American, Black-African, Black. 1000 Oriental Tattoo Designs.
Artist Amjad Farid. A traditional Arakanese tattoo pattern called 'Nokgal', inked on the right forearm of a man.
"I feel like I'm living the life of a warrior, the life of a samurai.
1000 Oriental Tattoo Designs.pdf
www.buttermilkbar.com, Asian, African American, Black-African, Black. 1000 Oriental Tattoo Designs.
'Much of the male population of the city had their faces tattooed'.. Japanese Tattoo Designs, Tattoo Symbols and Symbols.
"Oriental" tattoo style is a bit of a modern-day "trend", however, it has been around for thousands of years. .
1000 Oriental Tattoo Designs.pdf
www.buttermilkbar.com, Asian, African American, Black-African, Black. 1000 Oriental Tattoo Designs.
"One of the earliest Japanese tattoo symbols, the sacred tiger.
1000 Oriental Tattoo Designs.pdf
www.buttermilkbar.com, Asian, African American, Black-African, Black. 1000 Oriental Tattoo Designs.
"The oriental tattooing process has developed and evolved over the centuries. The designs used were similar to those used for etching Chinese characters. Cytotoxicity and cell cycle studies of a new antifolate drug in HeLa and MCF-7 cells.
A new antifolate drug, N-(2-bromo-4-trifluoromethyl-benzyl) guanidinium bromide, was tested in vitro on the human epithelial cancer cell line HeLa and the human mammary carcinoma MCF-7. The compound was found to induce a marked inhibition of DNA synthesis in both cell lines in a concentration-dependent manner. A decrease in protein synthesis was also observed in the latter. The drug was significantly more active than methotrexate in HeLa cells at equimolar concentrations. It is effective also in MCF-7 cells if the drug is added to the culture medium at higher concentrations. The results of the cell cycle analysis indicate that the effect on the cell cycle is mainly due to an inhibition of the progression through the G2 phase. The toxicity of the drug in the HEC-1A uterine carcinoma cell line ac619d1d87
Related links:
Comments